The U.S. Food and Drug Administration (FDA) recently issued a press release regarding a voluntary recall of certain lots of infant formula manufactured in Abbott Nutrition’s Sturgis, Michigan facility.
Visit www.fda.gov/news-events/press-announcements/fda-warns-consumers-not-use-certain-powdered-infant-formula-produced-abbott-nutritions-facility for more information.
The FDA encourages state and local agencies to collect and test consumer samples for Cronobacter sakazakii linked to this recall if they meet one of the following conditions:
- Your agency has received or is aware of a consumer complaint regarding an infant illness and the illness/complaint is associated with the recalled lots, or
- Your agency is aware of a confirmed Cronobacter sakazakii illness in an infant who consumed infant formula from one of the recall lots
Samples may be sent to your local laboratory, or to an FDA laboratory, for testing. Product and lot information should be obtained even if physical product samples are unavailable.
You may communicate and coordinate sample collection and testing efforts with the Division Director and State Liaison assigned to your state.
Agencies receiving an FDA cooperative agreement (such as the Laboratory Flexible Funding Model and Manufactured Foods Flexible Funding Model) may use these funds to perform this work.
Please contact your Office of Partnerships Project Manager if you have any questions about the use of cooperative agreement funds for this activity. Funds are readily available.
- [email protected], [email protected], or [email protected] for Lab Flexible Funding Model
- [email protected] or [email protected] for Manufactured Foods Flexible Funding Model (including Rapid Response Team)
You may also contact [email protected], 615-310-0483, for questions about the use of cooperative agreement funds, and Barbara Cassens, 510-418-5819, for any questions about this activity.
The FDA appreciates your partnership in this important public health issue!
